Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) was the recipient of a significant decline in short interest in April. As of April 28th, there was short interest totalling 936,844 shares, a decline of 33.9% from the April 13th total of 1,417,308 shares. Based on an average daily volume of 1,187,228 shares, the days-to-cover ratio is presently 0.8 days. Currently, 2.4% of the company’s stock are sold short.

A number of brokerages have commented on ZLTQ. Aegis restated a “hold” rating and issued a $56.00 target price on shares of Zeltiq Aesthetics in a research note on Monday, April 24th. Zacks Investment Research upgraded Zeltiq Aesthetics from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a research note on Thursday, April 13th. Leerink Swann downgraded Zeltiq Aesthetics from an “outperform” rating to a “market perform” rating in a research note on Tuesday, February 14th. Canaccord Genuity restated a “hold” rating and issued a $56.50 target price on shares of Zeltiq Aesthetics in a research note on Friday, March 10th. Finally, Northcoast Research downgraded Zeltiq Aesthetics from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 14th. Ten equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Zeltiq Aesthetics has an average rating of “Hold” and a consensus price target of $50.94.

Shares of Zeltiq Aesthetics (NASDAQ:ZLTQ) opened at 56.48 on Friday. The stock’s 50 day moving average price is $56.05 and its 200 day moving average price is $46.95. Zeltiq Aesthetics has a 1-year low of $23.58 and a 1-year high of $56.50.

In other Zeltiq Aesthetics news, insider Mark J. Foley sold 10,000 shares of the business’s stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $55.77, for a total value of $557,700.00. Following the transaction, the insider now owns 220,430 shares in the company, valued at $12,293,381.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Bradley Hauser sold 3,000 shares of the business’s stock in a transaction dated Tuesday, February 21st. The shares were sold at an average price of $55.64, for a total value of $166,920.00. Following the completion of the transaction, the senior vice president now owns 49,301 shares in the company, valued at approximately $2,743,107.64. The disclosure for this sale can be found here. Insiders own 15.60% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in ZLTQ. BlackRock Inc. boosted its position in Zeltiq Aesthetics by 136,866.2% in the first quarter. BlackRock Inc. now owns 4,407,573 shares of the medical equipment provider’s stock worth $245,106,000 after buying an additional 4,404,355 shares during the last quarter. New York State Teachers Retirement System boosted its position in Zeltiq Aesthetics by 0.4% in the first quarter. New York State Teachers Retirement System now owns 55,152 shares of the medical equipment provider’s stock worth $3,067,000 after buying an additional 200 shares during the last quarter. Morgan Stanley boosted its position in Zeltiq Aesthetics by 2.2% in the first quarter. Morgan Stanley now owns 209,351 shares of the medical equipment provider’s stock worth $11,643,000 after buying an additional 4,568 shares during the last quarter. UBS Group AG boosted its position in Zeltiq Aesthetics by 1,784.2% in the first quarter. UBS Group AG now owns 164,675 shares of the medical equipment provider’s stock worth $9,157,000 after buying an additional 155,935 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Zeltiq Aesthetics by 9.0% in the first quarter. Geode Capital Management LLC now owns 294,846 shares of the medical equipment provider’s stock worth $16,396,000 after buying an additional 24,290 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/05/13/zeltiq-aesthetics-inc-zltq-short-interest-update-2.html.

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.

5 Day Chart for NASDAQ:ZLTQ

Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with MarketBeat.com's FREE daily email newsletter.